Wang Qi
Investment Director @ Tonggao Capital
Wang Qi is a Series B investor at Tonggao Capital focused on Health Care and Biotechnology. Wang Qi is the Investment Director of Tonggao Capital.
- Total investments:
- 1
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Wang Qi invests in
Stages Wang Qi invests in
Countries Wang Qi invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
XinjingZhiyuan is an immune cell therapy company focusing on solid tumors. | $28.7M / Series B / Jan 26, 2026 |
Co-Investors
About Tonggao Capital
Tonggao Capital is an equity investment institution dedicated to investing in growth-stage companies.
Tonggao Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Wang Qi
Investment Director
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wang Qi invest in?
Wang Qi invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!